- Home
- LZB vs OLMA Comparison
LZB vs OLMA Comparison
Compare LZB & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LZB | OLMA |
|---|---|---|
| Founded | 1927 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LZB | OLMA |
|---|---|---|
| Price | $35.79 | $15.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $39.00 | ★ $44.89 |
| AVG Volume (30 Days) | 322.5K | ★ 738.5K |
| Earning Date | 06-16-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.75% | N/A |
| EPS Growth | N/A | ★ 15.00 |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $2,349,433,000.00 | N/A |
| Revenue This Year | $1.89 | N/A |
| Revenue Next Year | $2.09 | N/A |
| P/E Ratio | $21.48 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $29.03 | $3.89 |
| 52 Week High | $44.49 | $36.26 |
Technical Indicators
Market Signals| Indicator | LZB | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 56.82 | 43.64 |
| Support Level | $35.32 | $13.98 |
| Resistance Level | $39.79 | $17.23 |
| Average True Range (ATR) | 0.90 | 0.76 |
| MACD | -0.02 | 0.07 |
| Stochastic Oscillator | 66.62 | 33.98 |
Price Performance
Historical ComparisonAbout LZB La-Z-Boy Incorporated
La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.